RELMADA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
RELMADA THERAPEUTICS, INC. (RLMD) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 17.42 million shares as of 2023-12-31, per its 10-K filed 2024-03-19.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2024-03-19
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 17.42M shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 12.46M shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 12.48M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 12.12M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number as first filed |
|---|---|---|
| 2023-12-31 | 17.42M shares 10-K · filed 2024-03-19 | |
| 2023-09-30 | 12.46M shares 10-Q · filed 2023-11-08 | |
| 2023-06-30 | 12.48M shares 10-Q · filed 2023-08-08 | |
| 2022-12-31 | 12.12M shares 10-K · filed 2024-03-19 | |
| 2021-12-31 | 10.33M shares 10-K · filed 2024-03-19 | |
| 2021-03-31 | 2.38M shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 3.91M shares 10-K · filed 2023-03-23 | |
| 2019-12-31 | 3.62M shares 10-K · filed 2022-03-25 | |
| 2015-06-30 | 777.63K shares 10-K · filed 2015-09-11 | |
| 2014-06-30 | 673.03K shares 10-K · filed 2015-09-11 | 3.37M shares 10-KT · filed 2014-09-09 |
| 2014-03-31 | 30.15M shares 8-K · filed 2014-05-27 | |
| 2013-12-31 | 373.08K shares 10-K · filed 2015-09-11 | 18.65M shares 8-K · filed 2014-05-27 |
| 2012-12-31 | 135.59K shares 10-K · filed 2015-09-11 | 6.78M shares 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |